The purpose and effect of the proposed amendments are to repeal rules identified during the Department’s comprehensive rule review as duplicative of statute or no longer necessary. Rule 64B-1.004 addresses the conduct of exam administrators, ...

 

DEPARTMENT OF HEALTH

Division of Medical Quality Assurance

RULE NOS.:RULE TITLES:

64B-1.004Conduct at Test Site

64B-1.009Pre-hearing Review Request

PURPOSE AND EFFECT: The purpose and effect of the proposed amendments are to repeal rules identified during the Department’s comprehensive rule review as duplicative of statute or no longer necessary.

Rule 64B-1.004, F.A.C. addresses the conduct of exam administrators, proctors and applicants. Rule 64B-1.009, F.A.C. addresses the pre-hearing review pursuant to Rule 28-106.209, F.A.C. These rules are not incorporated in other rules and the repeal of these rules will not have an effect on other rules.

SUMMARY: To repeal rules identified as no longer necessary.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION: The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: the SERC checklist does not indicate that the statutory threshold for ratification will be exceeded. Any person who wishes to provide information regarding the statement of estimated regulatory costs, or to provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 456.004(5), 456.014, 456.017(1), 456.017(2) FS.

LAW IMPLEMENTED: 456.013(1), 456.014, 456.017(1) FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Lola Pouncey, [e-mail], Florida Department of Health, Division of Medical Quality Assurance, 4052 Bald Cypress Way, Bin C-01, Tallahassee, Florida 32399

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B-1.004 Conduct at Test Site

Rulemaking Authority 456.004(5), 456.017(1) FS. Law Implemented 456.017(1) FS. History–New 9-7-98, Amended 7-20-03, 9-30-09, Repealed.

 

64B-1.009 Pre-Hearing Review Request

Rulemaking Authority 456.004(5), 456.014, 456.017(2) FS. Law Implemented 456.014, 456.017 FS. History–New 9-7-98, Amended 2-21-00, 7-20-03, 6-19-08, 9-30-09, Repealed                                          .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Lola Pouncey

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: John H. Armstrong, MD, FACS, Surgeon General and Secretary

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: September 22, 2015